Mavacamten is a selective, reversible, allosteric cardiac myosin inhibitor. It is approved under the brand name Camzyos ® for the treatment of adults with symptomatic New York Heart Association class ...

A REPORT on a four year old study in Dar es Salaam Region has shown that original Covid-19 vaccines had reduced effectiveness ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

Pharmacology, prescribing requirements, and patient preference are crucial factors in choosing opioid agonist treatments.

MALAYSIA’S sixth Economic Census, which will cover about 1.3 million business establishments nationwide, has begun field ...

Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg ...

A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...

Objectives Although breastfeeding is associated with lower postnatal depression and anxiety, limited research exists regarding long-term maternal mental health outcomes. This study examined the ...

A high risk of obstructive sleep apnea (OSA) was associated with higher odds of a composite of depression and mental health ...

The ROAR trial tested the hypothesis that returning familial hypercholesterolemia-associated genetic results leads to ...

University of Queensland ecologist Dr Kate Dutton-Regester is leading a first-of-its-kind population survey in south-east ...